MBRX Moleculin Biotech, Inc. - Common Stock
$0,58
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$0–$13
3% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$18
+3055% upside
P/E (TTM)
—
ROE
—
Nettogewinnmarge
—
MBRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.58
Marktkapitalisierung
—
P/E (TTM)
—
EPS (TTM)
—
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
—
Verschuldungsgrad
—
52W-Spanne
$0 – $13
MBRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2016-12-31
→
2025-12-31
EPS
—
Freier Cashflow
—
2016-12-31
→
2022-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
MBRX
Peer-Median
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
MBRX
Peer-Median
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
MBRX
Peer-Median
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
MBRX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
MBRX
Peer-Median
MBRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 2 22,2%
- Kauf 6 66,7%
- Halten 1 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-08-18
Median
$22.00
Mittelwert
$18.33
← Unter allen Zielen
$0.58
Tief
$2.00
Hoch
$31.00
Median-Ziel
$22.00
+3685,9%
Mittelwert-Ziel
$18.33
+3054,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
3.8%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-3.54 | $-1.70 | -1.8% |
| 31. Dezember 2025 | $13.04 | $-6.24 | 19.3% |
| 30. September 2025 | $-17.00 | $-4.97 | -12.0% |
| 30. Juni 2025 | $-12.25 | $-9.26 | -3.0% |
| 31. März 2025 | $-17.25 | $-14.15 | -3.1% |
| 31. Dezember 2024 | $-9.32 | $-32.72 | 23.4% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MBRX | — | — | — | — | — | — |
| BCAB | — | -0.6 | — | — | — | — |
| TCRT | — | -1.5 | -50.0% | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| REVB | — | — | — | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | — |
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $16M | $18M | $19M | $19M | $14M | $13M | $11M | $10M | $5M | $1M | |
| SG&A Expense | $9M | $9M | $10M | $12M | $8M | $7M | $6M | $5M | $4M | $2M | |
| Operating Expenses | $25M | $27M | $30M | $31M | $23M | $20M | $18M | $15M | $9M | $4M | |
| Operating Income | $-25M | $-27M | $-30M | $-31M | $-23M | $-20M | $-18M | $-15M | $-9M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $43.0K | |
| Other Non-op | $-20.0K | $43.0K | $48.0K | $40.0K | $40.0K | $28.0K | $15.0K | $-40.0K | $9.0K | · | |
| Pretax Income | $-34M | $-26M | · | · | · | $-17M | $-13M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-229.0K | $0 | $0 | $0 | |
| Net Income | $-34M | $-26M | $-30M | $-29M | $-16M | $-17M | $-13M | $-12M | $-10M | $-4M | |
| EPS (Basic) | $-28.42 | $-189.14 | $-15.07 | $-15.22 | $-0.59 | · | · | · | · | · | |
| Shares (Basic) | 1,184,569 | 137,720 | 1,975,610 | 1,906,960 | 26,875,927 | · | · | · | · | · | |
| EBITDA | · | · | · | $-31M | $-23M | $-20M | $-17M | $-15M | $-9M | $-4M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $24M | $43M | $71M | $15M | $11M | $7M | $8M | $5M | |
| Receivables | · | · | · | · | · | · | $1.0K | $56.0K | · | · | |
| Prepaid Expense | $808.0K | $916.0K | $3M | $2M | $2M | $2M | $3M | $840.0K | $588.0K | $215.0K | |
| Other Current Assets | · | · | · | · | · | · | $529.0K | · | · | · | |
| Current Assets | $10M | $5M | $26M | $46M | $72M | $17M | $13M | $8M | $8M | $5M | |
| PP&E (Net) | $78.0K | $159.0K | $272.0K | $275.0K | $338.0K | $483.0K | $316.0K | $463.0K | $33.0K | $23.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | $57.0K | · | |
| Accum. Depreciation | $1M | $1M | $896.0K | $769.0K | · | $474.0K | $284.0K | $93.0K | $21.0K | $6.0K | |
| Other Non-current Assets | $900.0K | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $22M | $17M | $38M | $57M | $84M | $29M | $25M | $20M | $19M | $16M | |
| Accounts Payable | $4M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $810.0K | $399.0K | |
| Accrued Liabilities | $3M | $3M | $4M | $3M | $2M | $2M | $1M | $2M | $902.0K | $650.0K | |
| Current Liabilities | $7M | $5M | $7M | $5M | $4M | $3M | $4M | $4M | $2M | $1M | |
| Capital Leases | $222.0K | $358.0K | $474.0K | $335.0K | $63.0K | $159.0K | $276.0K | · | · | · | |
| Total Liabilities | $7M | $6M | $12M | $5M | $5M | $11M | $10M | $5M | $2M | $1M | |
| Common Stock | $3.0K | $0 | $33.0K | $29.0K | $29.0K | $69.0K | $46.0K | $29.0K | $21.0K | $12.0K | |
| Retained Earnings | $-206M | $-172M | $-132M | $-102M | $-73M | $-57M | $-40M | $-26M | $-14M | $-5M | |
| AOCI | $10.0K | $-41.0K | · | · | · | · | · | · | $0 | · | |
| Stockholders' Equity | $15M | $11M | $31M | $52M | $79M | $18M | $16M | $14M | $17M | $15M | |
| Liabilities + Equity | $22M | $17M | $38M | $57M | $84M | $29M | $25M | $20M | $19M | $16M | |
| Shares Outstanding | 3,199,228 | 135,155 | 2,227,516 | 1,908,523 | 28,578,338 | 11,536,720 | 7,621,338 | 28,528,663 | 21,469,109 | 12,164,852 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90.0K | $126.0K | $127.0K | $130.0K | $164.0K | $200.0K | $199.0K | $68.0K | $18.0K | $6.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $707.0K | $324.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-1M | $-6M | $-2M | $-6M | $-2M | $2M | $-168.7K | |
| Operating Cash Flow | $-23M | $-24M | $-24M | $-28M | $-19M | $-18M | $-17M | $-12M | $-7M | $-4M | |
| CapEx | $0 | $13.0K | $124.0K | $67.0K | $19.0K | $376.0K | $52.0K | $417.0K | $28.0K | $21.0K | |
| Investing Cash Flow | $0 | $-13.0K | $-124.0K | $-67.0K | $-19.0K | $-374.0K | $-51.0K | $-417.0K | $-28.0K | $-121.0K | |
| Stock Issued | · | · | · | $0 | $75M | $23M | $19M | · | · | · | |
| Net Stock Activity | · | · | · | $0 | $75M | $23M | · | · | · | · | |
| Financing Cash Flow | $27M | $5M | $4M | $-23.0K | $75M | $23M | $21M | $12M | $10M | $9M | |
| Net Change in Cash | $5M | $-19M | $-20M | $-28M | $56M | $4M | $4M | $-580.0K | $3M | $5M | |
| Taxes Paid | $0 | $0 | · | · | $15.0K | $24.0K | $19.0K | $21.0K | $0 | $0 | |
| Free Cash Flow | · | · | · | $-28M | $-19M | $-18M | $-17M | $-13M | $-7M | $-4M |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | · | -41.0% | -28.1% | -64.0% | -58.9% | -60.8% | -54.7% | -47.8% | |
| ROE | · | · | · | -52.5% | -19.8% | -107.7% | -76.4% | -81.2% | -61.1% | -55.2% | |
| ROIC | · | · | · | · | · | -111.2% | · | · | · | · |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 9.5 | 20.0 | 5.9 | 3.8 | 2.1 | 3.7 | 3.9 | |
| Quick Ratio | · | · | · | 9.0 | 19.6 | 5.2 | 3.0 | 1.8 | 3.5 | 3.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -89.9 |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | · | · | · |
Bewertung (TTM) 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-34M | $-26M | $-30M | $-29M | $-16M | $-17M | $-13M | $-12M | $-10M | $-4M | |
| Market Cap | · | · | · | · | $797M | $828M | $3.77B | $2.67B | $3.59B | $2.50B | |
| P/B | · | · | · | · | 10.1 | 46.6 | 241.8 | 187.1 | 210.0 | 166.9 | |
| P / Tangible Book | 0.7 | 0.5 | 0.9 | · | 10.1 | 46.6 | · | · | · | · | |
| P / Cash Flow | · | · | · | · | -42.1 | -46.6 | -219.0 | -218.8 | -490.7 | -663.0 | |
| P / FCF | · | · | · | · | -42.0 | -45.6 | -218.3 | -211.6 | -488.8 | -659.3 |
Gewinn- und Verlustrechnung 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $5M | $5M | $5M | $4M | $4M | $3M | $4M | $5M | $4M | $4M | $7M | $3M | $4M | $6M | $4M | $6M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Operating Expenses | $8M | $8M | $8M | $6M | $6M | $6M | $7M | $7M | $6M | $7M | $9M | $6M | $6M | $8M | $7M | $9M | |
| Operating Income | $-8M | $-8M | $-8M | $-6M | $-6M | $-6M | $-7M | $-7M | $-6M | $-7M | $-9M | $-6M | $-6M | $-8M | $-7M | $-9M | |
| Other Non-op | $13.0K | $76.0K | $-49.0K | $16.0K | $4.0K | $9.0K | $12.0K | $9.0K | $11.0K | $11.0K | $18.0K | $13.0K | $9.0K | $8.0K | $1.0K | $19.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-13M | $16M | $-25M | $-18M | $-6M | $-7M | $-7M | $-6M | $-6M | $-10M | $-6M | $-6M | $-8M | $-7M | $-9M | |
| EPS (Basic) | $-1.40 | $-3.54 | $-25.96 | $-0.68 | $-28.68 | $-15.80 | $-182.27 | $-1.89 | $-2.37 | $-2.61 | $-5.10 | $-2.82 | $-3.02 | $-4.13 | $-14.44 | $-0.30 | |
| Shares (Basic) | 5,680,717 | 4,124,482 | -60,990,058 | 37,304,455 | 621,056 | 373,751 | -8,585,976 | 3,714,278 | 2,543,244 | 2,466,174 | -3,907,596 | 1,987,283 | 1,979,258 | 1,916,665 | -83,882,002 | 28,627,610 | |
| EBITDA | $-8M | $-8M | · | $-6M | $-6M | $-6M | · | $-7M | $-6M | $-7M | · | $-6M | $-6M | $-8M | · | $-9M |
Bilanz 18
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $9M | $7M | $8M | $8M | $4M | $9M | $11M | $17M | $24M | $25M | $32M | $37M | $43M | $50M | |
| Prepaid Expense | $1M | $644.0K | $808.0K | $1M | $2M | $2M | $916.0K | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | |
| Current Assets | $9M | $11M | $10M | $8M | $9M | $9M | $5M | $12M | $14M | $19M | $26M | $28M | $35M | $39M | $46M | $53M | |
| PP&E (Net) | $62.0K | $70.0K | $78.0K | $77.0K | $99.0K | $127.0K | $159.0K | $190.0K | $221.0K | $240.0K | $272.0K | $225.0K | $229.0K | $244.0K | $275.0K | $306.0K | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $896.0K | · | · | · | $769.0K | · | |
| Other Non-current Assets | $900.0K | $900.0K | $900.0K | $900.0K | $900.0K | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Assets | $21M | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M | $31M | $38M | $40M | $47M | $51M | $57M | $65M | |
| Accounts Payable | $4M | $5M | $4M | $2M | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $2M | $4M | $2M | $2M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $3M | $3M | $3M | |
| Current Liabilities | $9M | $8M | $7M | $6M | $8M | $7M | $5M | $6M | $6M | $5M | $7M | $4M | $7M | $5M | $5M | $6M | |
| Capital Leases | $147.0K | $185.0K | $222.0K | $258.0K | $292.0K | $326.0K | $358.0K | $390.0K | $420.0K | $450.0K | $474.0K | $496.0K | $291.0K | $308.0K | $335.0K | $365.0K | |
| Total Liabilities | $10M | $8M | $7M | $47M | $29M | $21M | $6M | $16M | $8M | $9M | $12M | $4M | $7M | $5M | $5M | $7M | |
| Common Stock | $7.0K | $5.0K | $3.0K | $49.0K | $30.0K | $14.0K | $0 | $3.0K | $3.0K | $2.0K | $33.0K | $30.0K | $30.0K | $30.0K | $29.0K | $29.0K | |
| Retained Earnings | $-226M | $-219M | $-206M | $-222M | $-167M | $-160M | $-172M | $-151M | $-141M | $-137M | $-132M | $-121M | $-116M | $-110M | $-102M | $-95M | |
| AOCI | $-64.0K | $-52.0K | $10.0K | · | · | · | $-41.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $12M | $15M | $15M | $-27M | $-7M | $42.0K | $11M | $7M | $18M | $22M | $26M | $35M | $40M | $46M | $52M | $58M | |
| Liabilities + Equity | $21M | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M | $31M | $38M | $40M | $47M | $51M | $57M | $65M | |
| Shares Outstanding | 7,100,000 | 5,336,350 | 3,199,228 | 49,498,576 | 30,207,494 | 14,127,494 | 135,155 | 3,001,895 | 2,560,785 | 2,311,536 | 2,227,516 | 29,810,443 | 29,789,322 | 29,600,323 | 1,908,523 | 28,627,827 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $9.0K | $21.0K | $29.0K | $31.0K | $32.0K | $31.0K | $31.0K | $32.0K | $34.0K | $32.0K | $31.0K | $30.0K | $32.0K | $32.0K | |
| Stock-based Comp | $436.0K | $380.0K | $459.0K | $303.0K | $417.0K | $485.0K | $427.0K | $353.0K | $453.0K | $493.0K | $479.0K | $493.0K | $513.0K | $499.0K | $535.0K | $699.0K | |
| Other Non-cash | · | $6M | · | · | · | $1M | · | · | · | $-2M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-7M | $-6M | $-5M | $-7M | $-6M | $-5M | $-5M | $-6M | $-6M | $-7M | $-5M | $-8M | $-5M | $-6M | $-7M | $-8M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $81.0K | $28.0K | $15.0K | $0 | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-13.0K | $0 | $-81.0K | $-28.0K | $-15.0K | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $70.0K | $141.0K | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $141.0K | · | · | |
| Financing Cash Flow | $4M | $8M | $7M | $6M | $5M | $8M | $1.0K | $5M | $-25.0K | $0 | $4M | $-4.0K | $49.0K | $141.0K | $0 | $-11.0K | |
| Net Change in Cash | $-3M | $1M | $2M | $-854.0K | $-159.0K | $3M | $-5M | $-1M | $-6M | $-7M | $-1M | $-8M | $-5M | $-6M | $-7M | $-8M | |
| Free Cash Flow | · | · | · | · | · | $-5M | · | · | · | · | · | · | · | $-6M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -57.9% | · | -116.1% | -32.4% | -24.8% | · | -33.7% | -11.9% | -12.1% | · | -10.7% | -9.9% | -12.2% | · | -11.2% | |
| ROE | -345.3% | -168.7% | · | 261.3% | -145.0% | -59.5% | · | -49.7% | -14.9% | -14.8% | · | -12.0% | -11.2% | -13.4% | · | -12.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 1.4 | · | 1.4 | 1.1 | 1.4 | · | 2.1 | 2.4 | 3.5 | · | 7.1 | 5.4 | 7.8 | · | 8.4 | |
| Quick Ratio | 0.8 | 1.3 | · | 1.2 | 1.0 | 1.1 | · | 1.7 | 1.9 | 3.1 | · | 6.3 | 4.9 | 7.4 | · | 7.9 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Bewertung (TTM) 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-64M | $-62M | · | $-56M | $-37M | $-25M | · | $-25M | $-24M | $-26M | · | $-28M | $-29M | $-30M | · | $-27M | |
| Market Cap | $20M | $12M | · | $26M | $9M | $14M | · | $9M | $9M | $14M | · | $191M | $259M | $426M | · | $455M | |
| P/B | 1.7 | 0.8 | · | -1.0 | -1.3 | 327.6 | · | 1.1 | 0.5 | 0.6 | · | 5.4 | 6.4 | 9.3 | · | 7.8 | |
| P / Tangible Book | 1.7 | 0.8 | · | · | · | 327.6 | · | 1.1 | 0.5 | 0.6 | · | 5.4 | 6.4 | 9.3 | · | 7.8 | |
| P / Cash Flow | · | -2.0 | · | · | · | -3.0 | · | · | · | -2.0 | · | · | · | -70.8 | · | · | |
| P / FCF | · | · | · | · | · | -3.0 | · | · | · | · | · | · | · | -70.8 | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $0 | $0 | $0 | $0 | $0 |
| Nettoergebnis | $-34M | $-26M | $-30M | $-29M | $-16M |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | — | — | — | 9.5 | 20.0 |
| Quick Ratio | — | — | — | 9.0 | 19.6 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | — | — | — | $-28M | $-19M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 20 Einreicher · $441K gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 7 (+3 vs. Vorquartal) | 6 (+3 vs. Vorquartal) | 4 (-1 vs. Vorquartal) | 0 (-1 vs. Vorquartal) | +32K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $117.780 | 42.215 | 26,73% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $114.057 | 40.881 | 25,88% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $83.374 | 29.883 | 18,92% | Aktien |
| XTX Topco Ltd | $64.008 | 22.942 | 14,53% | Aktien |
| Rockefeller Capital Management L.P. | $41.850 | 15.000 | 9,50% | Aktien |
| CITIGROUP INC | $7.460 | 2.674 | 1,69% | Aktien |
| Tower Research Capital LLC (TRC) | $5.379 | 1.928 | 1,22% | Aktien |
| BARCLAYS PLC | $1.733 | 621 | 0,39% | Aktien |
| BlackRock, Inc. | $1.370 | 491 | 0,31% | Aktien |
| EFG International AG | $1.211 | 434 | 0,27% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $1.177 | 360 | 0,27% | Aktien |
| WELLS FARGO & COMPANY/MN | $558 | 200 | 0,13% | Aktien |
| NFSG Corp | $318 | 114 | 0,07% | Aktien |
| SBI Securities Co., Ltd. | $123 | 44 | 0,03% | Aktien |
| Sandy Spring Bank | $87 | 89 | 0,02% | Aktien |
| VANGUARD GROUP INC | $79 | 24 | 0,02% | Aktien |
| MORGAN STANLEY | $56 | 20 | 0,01% | Aktien |
| DANSKE BANK A/S | $6 | 2 | 0,00% | Aktien |
| CVA Family Office, LLC | $3 | 1 | 0,00% | Aktien |
| OSAIC HOLDINGS, INC. | $2 | 1 | 0,00% | Aktien |
Unternehmensinsider 8 Insider · 0 Führungskräfte · 4 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert E. George | Direktor | 22. Mai 2019 A | 1.000 | 0 | 0 | $0 |
| John M Climaco | Direktor | 22. Mai 2019 A | — | 0 | 0 | $0 |
| Michael D Cannon | Direktor | 22. Mai 2019 A | — | 0 | 0 | $0 |
| Jacqueline Northcut | Direktor | 5. Mai 2017 P | 1.000 | 0 | 0 | $0 |
| Waldemar Priebe | 10%-Eigentümer | 16. August 2017 S | 2.781.573 | 0 | 0 | $0 |
| Jonathan P. Foster | — | 3. August 2026 P | 305.673 | 0 | 0 | $0 |
| Donald H Picker | — | 3. August 2026 P | 174.086 | 0 | 0 | $0 |
| Walter V Klemp | — | 3. August 2026 A | 564.340 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 1 ETF
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 42.215 SH | 8. August 2026 | Täglich |